DNL
WisdomTree Global ex-U.S. Quality Growth Fund
Set alert
43.29 USD -1.33 -2.98%
42.91 Day range 43.61
38.95 52-week range 47.24
- YTD
- +5.01%
- 1 year
- +4.86%
- Open
- 43.61
- Prev close
- 44.62
- Mkt cap
- 476.56M
- Vol
- 17.13K
- Avg vol
- 16.15K
- EPS
- 1.88
- P/E
- 23.04
- Div yield
- 0.00%
More statistics
- Low
- 42.91
- High
- 43.61
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 37.56
- 200-d avg
- 38.59
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 19.29
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 37.56
- 200-day average
- 38.59
About WisdomTree Global ex-U.S. Quality Growth Fund
Under normal circumstances, at least 95% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in constituent securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such constituent securities. The index is a fundamentally weighted index that consists of dividend-paying global ex-U.S. common stocks with growth characteristics. The fund is non-diversified.
News
- What's Going On With Shopify Stock Tuesday?
- The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics' Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
- Denali: Maintaining Strong Buy Based On DNL126 Expansion As MPS IIIA Treatment
- Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
- Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
- Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
- DNL: Lagging Its Peers For A While
- Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
- Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
- Denali Therapeutics: Vast Pipeline, First Approval Up Ahead
Your note
Sign in to keep a note on DNL — it syncs with the Stock Master app.